EA200602016A1 - ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ - Google Patents

ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ

Info

Publication number
EA200602016A1
EA200602016A1 EA200602016A EA200602016A EA200602016A1 EA 200602016 A1 EA200602016 A1 EA 200602016A1 EA 200602016 A EA200602016 A EA 200602016A EA 200602016 A EA200602016 A EA 200602016A EA 200602016 A1 EA200602016 A1 EA 200602016A1
Authority
EA
Eurasian Patent Office
Prior art keywords
enantiomerna
agentists
clean
powder compositions
inhalation containing
Prior art date
Application number
EA200602016A
Other languages
English (en)
Other versions
EA012582B1 (ru
Inventor
Михаэль Трунк
Йёрг Шиве
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35058202&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200602016(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA200602016A1 publication Critical patent/EA200602016A1/ru
Publication of EA012582B1 publication Critical patent/EA012582B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Abstract

В заявке описаны порошковые композиции для ингаляции, содержащие энантиомерночистые соединения общей формулы ()в которой остатки R, R, Rи Rмогут иметь указанные в формуле изобретения и описании значения, необязательно в виде их фармацевтически приемлемых кислотно-аддитивных солей, а также необязательно в сочетании с фармацевтически приемлемым вспомогательным веществом, а также описаны способ их получения и их применение в качестве лекарственных средств, прежде всего в качестве лекарственных средств для лечения заболеваний дыхательных путей.
EA200602016A 2004-05-14 2005-05-11 ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ EA012582B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004024451A DE102004024451A1 (de) 2004-05-14 2004-05-14 Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
PCT/EP2005/005078 WO2005110359A1 (de) 2004-05-14 2005-05-11 Pulverformulierungen für die inhalation, die enantiomerenreine betaagonisten enthalten

Publications (2)

Publication Number Publication Date
EA200602016A1 true EA200602016A1 (ru) 2007-06-29
EA012582B1 EA012582B1 (ru) 2009-10-30

Family

ID=35058202

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602016A EA012582B1 (ru) 2004-05-14 2005-05-11 ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ

Country Status (24)

Country Link
EP (1) EP1809236B1 (ru)
JP (1) JP4891899B2 (ru)
KR (1) KR101270449B1 (ru)
CN (1) CN1984638A (ru)
AR (1) AR048899A1 (ru)
AU (1) AU2005244424B2 (ru)
BR (1) BRPI0511136A (ru)
CA (1) CA2565915C (ru)
DE (1) DE102004024451A1 (ru)
DK (1) DK1809236T3 (ru)
EA (1) EA012582B1 (ru)
ES (1) ES2401786T3 (ru)
IL (1) IL179215A (ru)
MX (1) MXPA06013221A (ru)
MY (1) MY145838A (ru)
NO (1) NO20065078L (ru)
PE (1) PE20060239A1 (ru)
PL (1) PL1809236T3 (ru)
SG (1) SG152258A1 (ru)
TW (1) TW200607508A (ru)
UA (1) UA86807C2 (ru)
UY (1) UY28896A1 (ru)
WO (1) WO2005110359A1 (ru)
ZA (1) ZA200607785B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
NZ566068A (en) 2005-08-08 2011-03-31 Argenta Discovery Ltd Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
JP5270343B2 (ja) 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータミメティックスの製造方法
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
US8362064B2 (en) 2008-12-30 2013-01-29 Pulmagen Theraputics (Inflammation) Limited Sulfonamide compounds for the treatment of respiratory disorders
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
JP2015533131A (ja) 2012-10-09 2015-11-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 咳を治療するためのベータ２−アドレナリン受容体作動薬
WO2018108669A1 (en) 2016-12-12 2018-06-21 Boehringer Ingelheim International Gmbh Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
BR0110331A (pt) * 2000-04-27 2003-01-07 Boehringer Ingelheim Pharma Substâncias que mimetizam beta que têm uma atividade de longa duração, processos para prepará-las e o uso das mesmas como medicamentos
GB0107106D0 (en) * 2001-03-21 2001-05-09 Boehringer Ingelheim Pharma Powder inhaler formulations
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
KR101270449B1 (ko) 2013-06-04
PE20060239A1 (es) 2006-03-27
WO2005110359A1 (de) 2005-11-24
KR20070016169A (ko) 2007-02-07
AU2005244424B2 (en) 2010-12-23
CN1984638A (zh) 2007-06-20
ZA200607785B (en) 2008-07-30
UY28896A1 (es) 2005-12-30
SG152258A1 (en) 2009-05-29
IL179215A (en) 2011-04-28
JP2007537195A (ja) 2007-12-20
EP1809236B1 (de) 2012-12-26
MY145838A (en) 2012-04-30
IL179215A0 (en) 2007-03-08
UA86807C2 (ru) 2009-05-25
AR048899A1 (es) 2006-06-07
DK1809236T3 (da) 2013-02-11
EA012582B1 (ru) 2009-10-30
PL1809236T3 (pl) 2013-05-31
NO20065078L (no) 2006-11-28
ES2401786T3 (es) 2013-04-24
MXPA06013221A (es) 2007-02-08
DE102004024451A1 (de) 2005-12-22
CA2565915A1 (en) 2005-11-24
CA2565915C (en) 2013-12-10
TW200607508A (en) 2006-03-01
JP4891899B2 (ja) 2012-03-07
BRPI0511136A (pt) 2007-11-27
EP1809236A1 (de) 2007-07-25
AU2005244424A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
EA200602016A1 (ru) ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
ATE369353T1 (de) Medizinisch verwendbare arylethanolamin verbindungen
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
EA200970224A1 (ru) Лечение заболеваний хряща
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
WO2008154083A3 (en) Compounds, compositions and methods for the treatment of synucleinopathies
DK1885333T3 (da) Farmaceutisk formulering af apomorphin til bukkal indgivelse
MXPA05007857A (es) Moduladores derivados de indol de receptores nucleares de hormonas esteroideas.
WO2011118976A3 (en) Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
EA200701615A1 (ru) Новые лекарственные средства для лечения заболеваний дыхательных путей
EA200500902A1 (ru) Порошковые лекарственные средства, содержащие соль тиотропия и ксинафоат салметерола
HK1079526A1 (en) A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin
RS98704A (en) New pharmaceutical compositions containing flibanserin polymorpha
SE0402925D0 (sv) Novel Compounds
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
MX2009008463A (es) Formulaciones biodisponibles de compuestos heterociclicos.
EA200600854A1 (ru) Новые соли тиотропия, способ их получения, а также содержащие их лекарственные композиции
EA200600886A1 (ru) Способ получения солей тиотропия, соли тиотропия, а также содержащие их лекарственные композиции
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU